KreaMedica

KreaMedica, based in Montreal, Quebec, Canada, provides functional outsourcing for drug development, managing programs from lead candidate selection through non-clinical safety assessments and early clinical trials. The firm offers expertise in toxicology study design, bioanalytical assays, preclinical development, DMPK, formulation, pharmacology, and bioanalysis for biotech and pharma clients. With an estimated valuation of $3.1 million and annual revenue of $941,105, KreaMedica operates with 11-20 employees. Key personnel include President & CEO Karl-Rudolf (Rudi) Erlemann, Director of Business Development Vik Pham, and Senior Director R&D Operations Marie-Josée Lachapelle. The company has managed and executed over 150 development programs. KreaMedica was founded in 2009 by Karl-Rudolf (Rudi) Erlemann. Its business model centers on service-based consultancy and project management in drug development outsourcing, no known external funding.